Current Surgical

Executive Summary

Current Surgical is a private medical device company based in Redwood City, California, that is reinventing surgery for the modern era. Founded in 2016, the company is developing a digital surgery platform that integrates real-time ultrasound imaging, focused ultrasound energy delivery, and AI-driven algorithms. This platform aims to enable precise, minimally invasive treatment of early-stage solid tumors and other conditions, providing surgeons with millimeter-level control in areas where traditional techniques often fail. By combining imaging and therapeutic ultrasound with artificial intelligence, Current Surgical seeks to improve outcomes, reduce invasiveness, and expand treatment options for patients with solid tumors. The company's technology addresses a significant unmet need in oncology, where early-stage tumors are often difficult to treat with conventional surgery or ablation. The digital surgery platform has the potential to offer a more precise and less invasive alternative, which could reduce recovery times and complications. While Current Surgical is still in a developmental stage and has not yet commercialized a product, its innovative approach and focus on precision medicine position it as a promising player in the surgical robotics and tumor ablation space. The company faces typical early-stage risks, including regulatory hurdles and the need for clinical validation, but its platform could disrupt traditional surgical paradigms if successful.

Upcoming Catalysts (preview)

• TBDFirst-in-human clinical trial results60% success
• Q4 2026FDA 510(k) clearance or investigational device exemption (IDE) approval50% success
• TBDKey strategic partnership or Series B funding80% success